Get the Stockscreener App
17.69
20.49%
-4.56
Progyny Inc stock is traded at $17.69, with a volume of 5.19M.
It is down -20.49% in the last 24 hours and down -27.05% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$22.25
Open:
$19.88
24h Volume:
5.19M
Relative Volume:
3.62
Market Cap:
$1.53B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
28.08
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-15.68%
1M Performance:
-27.05%
6M Performance:
-23.15%
1Y Performance:
-22.68%
1-Day Range:
$16.75
$20.22
1-Week Range:
$16.75
$22.33
52-Week Range:
$16.75
$28.75
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
17.69 | 1.92B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
293.27 | 259.67B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
79.90 | 99.25B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
289.82 | 76.09B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
320.00 | 71.30B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
190.54 | 22.47B | 126.36B | 1.30B | 1.55B | 10.67 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny earnings up next: Retention strength meets new growth push By Investing.com - Investing.com UK
Progyny Q4 2025 Earnings Preview: Revenue Slowdown AnticipatedNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Seeking Clues to Progyny (PGNY) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
What To Expect From Progyny Inc (PGNY) Q4 2025 Earnings - GuruFocus
Is Progyny (PGNY) Offering A Long-Term Opportunity After Recent Share Price Weakness - simplywall.st
Progyny (PGNY) Q4 Earnings Report Preview: What To Look For - Finviz
Advisors Preferred LLC Takes $1.07 Million Position in Progyny, Inc. $PGNY - MarketBeat
Is Progyny Inc. stock supported by strong cash flowsWeekly Trend Recap & Capital Efficient Trading Techniques - mfd.ru
Technical Analysis: Is Progyny Inc impacted by rising ratesTrade Ideas & Reliable Price Breakout Signals - baoquankhu1.vn
MSN Money - MSN
(PGNY) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Progyny (PGNY) Expected to Announce Earnings on Thursday - MarketBeat
Quarterly Trades: Is Progyny Inc a good ESG investment2025 Key Highlights & Expert Verified Movement Alerts - baoquankhu1.vn
CenterBook Partners LP Acquires 310,516 Shares of Progyny, Inc. $PGNY - MarketBeat
Public Sector Pension Investment Board Buys 104,026 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (NASDAQ:PGNY) Passes the Caviar Cruise Quality Investing Screen - ChartMill
Progyny, Inc. (NASDAQ:PGNY) Sees Large Decrease in Short Interest - MarketBeat
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report - Bluefield Daily Telegraph
Progyny, Inc. to Announce Q4 and Full Year 2025 Financial Results on February 26, 2026 - Quiver Quantitative
Progyny Adjusts Evaluation Amid Strong Growth and Financial Resilience - Markets Mojo
Progyny, Inc. $PGNY Shares Purchased by Principal Financial Group Inc. - MarketBeat
(PGNY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Progyny, Inc. (NASDAQ:PGNY) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Progyny Breaks Below 200-Day Moving AverageNotable for PGNY - Nasdaq
Progyny’s Financial Milestone: Upcoming Report to Set Direction - AD HOC NEWS
Progyny, Inc. $PGNY Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Sees Significant Decline in Short Interest - MarketBeat
Progyny (NASDAQ:PGNY) Aligns With Nasdaq 100 Composition Healthcare Themes - Kalkine Media
Assessing Progyny (PGNY) Valuation After Recent Share Pullback And 3‑Month Rebound - Yahoo Finance
(PGNY) Risk Channels and Responsive Allocation - Stock Traders Daily
105,000 Shares in Progyny, Inc. $PGNY Acquired by Hussman Strategic Advisors Inc. - MarketBeat
Progyny, Inc. (PGNY) Investor Outlook: Analyzing a Promising 24.43% Potential Upside in Healthcare Plans - DirectorsTalk Interviews
Kornitzer Capital Management Inc. KS Sells 85,000 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny Inc (NASDAQ:PGNY) Combines Strong Fundamentals with Bullish Technical Setup - ChartMill
Published on: 2026-01-27 11:06:26 - baoquankhu1.vn
US Market Recap: Why is Progyny Inc stock going downMarket Movers & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Bull Run: Is Progyny Inc forming a bullish divergenceMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
Progyny, Inc. (PGNY) supported by analysts as earnings visibility improves - MSN
Hedge Fund Bets: How do insiders feel about ProShares Trust ProShares Ultra SemiconductorsJuly 2025 Price Swings & Expert Approved Trade Ideas - baoquankhu1.vn
Wall Street Recap: What analysts say about Progyny Inc stockTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Progyny price target raised to $35 from $30 at BTIG - Yahoo Finance
SG Americas Securities LLC Cuts Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves - Insider Monkey
Progyny Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily
ETF Watch: Is Progyny Inc stock technically oversold2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn
Progyny (PGNY) Stock Rises on Analyst Upgrade to Market Outperform | 2026 OutlookNews and Statistics - IndexBox
Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz
Progyny sees IBD RS rating climb to 77 - MSN
Forecasting The Future: 6 Analyst Projections For Progyny - Benzinga
Progyny (NASDAQ:PGNY) Upgraded by Citizens Jmp to "Market Outperform" Rating - MarketBeat
Citizens Upgrades Progyny (PGNY) - Nasdaq
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.88%
5.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):